A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Nirogacestat Versus Placebo in Adult Patients With Progressing Desmoid Tumors/Aggressive Fibromatosis (DT/AF)
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
SpringWorks Therapeutics
Start Date
April 24, 2019
End Date
March 31, 2024
Administered By
Duke Cancer Institute
Awarded By
SpringWorks Therapeutics
Start Date
April 24, 2019
End Date
March 31, 2024